Angiogenesis and Microvascular Modeling The primary commercial application for the peptide bpc 157 centers on how tissues heal after structural injury
For example, cystic fibrosis patients suffer from severe gram-negative bacterial infections and are commonly prescribed the aminoglycoside antibiotics amikacin or tobramycin, despite as high as a 14% incidence of hearing loss (Cheng et al., 2007
DSIP is not FDA-approved for insomnia, sleep disorders, anxiety, recovery, or wellness
European Medicines Agency (EMA) approval pathways for peptides are generally similar to FDA processes, facilitating concurrent development for both markets
Reconstituting in unbuffered water and assuming neutral pH leads to variability
References: International Study of Asthma and Allergies in Childhood (ISAAC) Acetaminophen and Asthma Risk Glutathione Depletion & Acetaminophen in Asthma Risk